Private Assets Are Coming to Your Portfolio…Be Ready01 Oct 202627mMotley Fool Hidden Gems InvestingProcessed
Why the RBA Could Hike Again in November | The Bloomberg Australia Podcast01 Oct 2026Bloomberg PodcastsProcessed
The 10-Year Just Hit 5.3%. Brent Kochuba Says That's the Line Stocks Can't Ignore.01 Oct 2026tastyliveProcessed
Global Bonds Shock: Special Episode | Bloomberg Daybreak: Europe Edition01 Oct 2026Bloomberg PodcastsProcessed
You Won’t Believe What McDonald’s Just Revealed About U.S. Consumers30 Sep 2026Eurodollar UniversityProcessed
Podcast Episode: Why diesel prices are breaking records01 Oct 2026International Energy AgencyProcessed
The Shocking Reason Gas Prices Can’t Come Down Anytime Soon | Rory Johnston01 Oct 2026David Lin Processed
4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky25 Sep 20262h 12mTBPNProcessed
Is Hunter Biden's $LAPTOP Coin a Scam? He Says the Wallets Prove It Isn't01 Oct 202655mUnchainedProcessed
What Do Kidney Failure, Short Kids and the Vagus Nerve Have in Common?19 Dec 202554mDerms on DrugsProcessed
Si Sheppard – How did a few hundred Spanish soldiers topple two empires?01 Oct 20261h 37mDwarkesh PodcastProcessed
Apple Wants to Take Over Your Home. Is Siri Finally Ready?01 Oct 202634mPower On with Mark GurmanProcessed
Why you shouldn't ever use Bactrim for acne (and other new info you don't want to miss)30 Jan 202650mDerms on DrugsProcessed
Tissue Issues: A Deep Dive into Cutaneous Connective Tissue Disease06 Mar 20261h 6mDerms on DrugsProcessed